JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Sees Large Decrease in Short Interest

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 168,500 shares, a decrease of 44.8% from the February 28th total of 305,100 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

JCR Pharmaceuticals Stock Performance

JCR Pharmaceuticals stock remained flat at $4.57 during mid-day trading on Friday. The firm’s fifty day moving average is $4.57 and its 200 day moving average is $4.58. JCR Pharmaceuticals has a fifty-two week low of $4.30 and a fifty-two week high of $4.70.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.